Amerx began operations in 1993 and manufactures proprietary wound and skin products, including the Amerigel Skin and Wound Care product line with Oakin. All manufacturing is done in the United States and complies with rigid cGMP requirements. Amerigel products have been reviewed by the FDA (US Food & Drug Administration) and have individual NDC (National Drug Code) assigned to them.